Abstract
Joint cartilage has been a significant focus on the field of tissue engineering and regenerative medicine (TERM) since its inception in the 1980s. Represented by only one cell type, cartilage has been a simple tissue that is thought to be straightforward to deal with. After three decades, engineering cartilage has proven to be anything but easy. With the demographic shift in the distribution of world population towards ageing, it is expected that there is a growing need for more effective options for joint restoration and repair. Despite the increasing understanding of the factors governing cartilage development, there is still a lot to do to bridge the gap from bench to bedside. Dedicated methods to regenerate reliable articular cartilage that would be equivalent to the original tissue are still lacking. The use of cells, scaffolds and signalling factors has always been central to the TERM. However, without denying the importance of cells and signalling factors, the question posed in this chapter is whether the answer would come from the methods to use or not to use scaffold for cartilage TERM. This paper presents some efforts in TERM area and proposes a solution that will transpire from the ongoing attempts to understand certain aspects of cartilage development, degeneration and regeneration. While an ideal formulation for cartilage regeneration has yet to be resolved, it is felt that scaffold is still needed for cartilage TERM for years to come.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
References
WHO (2018) The WHO register. https://www.who.int/news-room/fact-sheets/detail/ageing-and-health. Accessed 11 Dec 2019
Benders KE, Terpstra ML, Levato R et al (2019) Fabrication of decellularized cartilage-derived matrix scaffolds. JoVE 143:e58656
Hazwani A, Sha’Ban M, Azhim A (2019) Characterization and in vivo study of decellularized aortic scaffolds using closed sonication system. Organogenesis 15(4):120–136
Wiggenhauser PS, Schwarz S, Koerber L et al (2019) Addition of decellularized extracellular matrix of porcine nasal cartilage improves cartilage regenerative capacities of PCL-based scaffolds in vitro. J Mater Sci Mater Med 30(11):121
Yusof F, Sha’ban M, Azhim A (2019) Development of decellularized meniscus using closed sonication treatment system: potential scaffolds for orthopedics tissue engineering applications. Int Nanomed 14:5491–5502
Ahmad M, Manzoor K, Ikram S (2019) Chitosan nanocomposites for bone and cartilage regeneration. In: Jamia MI (ed) Applications of nanocomposite materials in dentistry. Woodhead Publishing, New Delhi, pp 307–317
Izzo D, Palazzo B, Scalera F et al (2019) Chitosan scaffolds for cartilage regeneration: influence of different ionic crosslinkers on biomaterial properties. Int J Polym Mater Polym Biomater 68(15):936–945
Roffi A, Kon E, Perdisa F (2019) A composite chitosan-reinforced scaffold fails to provide osteochondral regeneration. Int J Mol Sci 20(9):2227
Wang K, Li J, Li Z et al (2019) Chondrogenic progenitor cells exhibit superiority over mesenchymal stem cells and chondrocytes in platelet-rich plasma scaffold-based cartilage regeneration. Am J Sports Med 47(9):2200–2215
Chen K, Li X, Li N et al (2019) Spontaneously formed spheroids from mouse compact bone-derived cells retain highly potent stem cells with enhanced differentiation capability. Stem Cells 2019:1–13
Chen W, Xu Y, Liu Y, Wang Z et al (2019) Three-dimensional printed electrospun fiber-based scaffold for cartilage regeneration. Mater Des 179:1–13
Li J, Chen G, Xu X et al (2019a) Advances of injectable hydrogel-based scaffolds for cartilage regeneration. Regen Biomater 6(3):129–140
Rogan H, Ilagan F, Yang F (2019) Comparing single cell versus pellet encapsulation of mesenchymal stem cells in three-dimensional hydrogels for cartilage regeneration. Tissue Eng Part A 25:1–27
De Pascale C, Marcello E, Getting SJ et al (2019) Populated collagen hydrogel and polyhydroxyalkanoate composites: novel matrices for cartilage repair and regeneration? Osteoarthr Cartil 27:S432–S433
Baena JM, Jiménez G, López-Ruiz E, Antich C et al (2019) Volume-by-volume bioprinting of chondrocytes-alginate bioinks in high-temperature thermoplastic scaffolds for cartilage regeneration. Exp Biol Med 244(1):13–21
Farokhi M, Jonidi Shariatzadeh F, Solouk A (2019) Alginate based scaffolds for cartilage tissue engineering: a review. Int J Polym Mater Polym Biomater 69:1–18
Farokhi M, Mottaghitalab F, Fatahi Y et al (2019) Silk fibroin scaffolds for common cartilage injuries: possibilities for future clinical applications. Eur Polym J 115:251–267
Lin H, Beck AM, Shimomura K (2019) Optimization of photocrosslinked gelatin/hyaluronic acid hybrid scaffold for the repair of cartilage defect. J Tissue Eng Regen Med 2019:1–12
Li J, Yao Q, Xu Y (2019b) Lithium chloride-releasing 3D printed scaffold for enhanced cartilage regeneration. Med Sci Monit 25:4041
Park IS, Jin RL, Oh HJ et al (2019) Sizable scaffold-free tissue-engineered articular cartilage construct for cartilage defect repair. Artif Organs 43(3):278–287
Sivadas VP, Dhawan S, Babu J (2019) Glutamic acid-based dendritic peptides for scaffold-free cartilage tissue engineering. Acta Biomater 99:196–210
De Moor L, Beyls E, Declercq H (2019) Scaffold free microtissue formation for enhanced cartilage repair. Ann Biomed Eng 48:1–14
Aguilar IN, Olivos DJ III, Brinker A et al (2019) Scaffold-free bioprinting of mesenchymal stem cells using the Regenova printer: spheroid characterization and osteogenic differentiation. Bioprinting 15:e00050
Breathwaite EK, Weaver JR, Murchison AC et al (2019) Scaffold-free bioprinted osteogenic and chondrogenic systems to model osteochondral physiology. Biomed Mater 14(6):065010
Lu Y, Zhang W, Wang J et al (2019) Recent advances in cell sheet technology for bone and cartilage regeneration: from preparation to application. Int J Oral Sci 11(2):1–13
Martini FH, Nath JL, Bartholomew EF (2018) Fundamentals of anatomy & physiology, 11th edn. Pearson Education, Inc, New York
Tortora GJ, Derrickson B (2017) Principles of human anatomy & physiology, 15th edn. Wiley, Milton
Saladin KS, Gan CA, Cushman HN (2018) Anatomy & physiology: the unity of form and function, 8th edn. McGraw-Hill Education, New York
Shier D, Butler J, Lewis R (2016) Hole’s human anatomy & physiology, 14th edn. McGraw-Hill Education, New York
Muriel R, Birgit R, William MK (2019) Cellular senescence in development, regeneration and disease. Development 146:dev151837
Myohara M (2004) Differential tissue development during embryogenesis and regeneration in an annelid. Dev Dyn 231:349–358
Kuhn LT, Liu Y, Boyd NL et al (2014) Developmental-like bone regeneration by human embryonic stem cell-derived mesenchymal cells. Tissue Eng Part A 20(1–2):365–377
Tetsuya E, Susan VB, David M (2004) A stepwise model system for limb regeneration. Dev Biol 270(1):135–145
Angela YC, Vegard FS, Stefanos T et al (2019) Measuring population ageing: an analysis of the global burden of disease study 2017. Lancet Public Health 4(3):e159–e167
Theo V, Abraham DF, Mohsen N et al (2012) Years lived with disability (YLDs) for 1160 sequelae of 289 diseases and injuries 1990–2010: a systematic analysis for the global burden of disease study 2010. Lancet 380(9859):2163–2196
Malaysia health technology assessment section (MaHTAS) (2013) Quick reference (QR): management of osteoarthritis, 2nd edn. Ministry of Health (MOH), Malaysia
Malaysia Health Technology Assessment Section (MaHTAS) (2013) Clinical practice guidelines (CPG): management of osteoarthritis, 2nd edn. Ministry of Health (MOH), Malaysia
Francis SL, Di Bella C, Wallace GG (2018) Cartilage tissue engineering using stem cells and bioprinting technology–barriers to clinical translation. Front Surg 5:70
Xue K, Zhang X, Gao Z (2019) Cartilage progenitor cells combined with PHBV in cartilage tissue engineering. J Transl Med 17(1):104
Catacchio I, Berardi S, Reale A et al (2013) Evidence for bone marrow adult stem cell plasticity. In: Prancla R(ed) properties, molecular mechanisms, negative aspects, and clinical applications of hematopoietic and mesenchymal stem cells transdifferentiation. Stem Cells Int 2013:1–11
Md Nazir N, Zulkifly AH, Khalid KA et al (2019) Matrix production in chondrocytes transfected with sex determining region Y-box 9 and telomerase reverse transcriptase genes: an in vitro evaluation from monolayer culture to three-dimensional culture. Tissue Eng Regen Med 16:285
Tahir AH, Azhim A, Sha’ban M et al (2017) Chondrocytes-induced SOX5/6/9 and TERT genes for articular cartilage tissue engineering: HYPE or Hope? Trans Persatuan Genetik Malaysia 7:151–160
Ahmad R, Muhammad A, Abdulahi H et al (2017) The application of gene transfer technology in articular cartilage tissue engineering: an insight. TPGM 7:211–216
Mohamed Amin MAI, Azhim A, Mohamed Sideek MA et al (2017) Current trends in gene-enhanced tissue engineering for articular cartilage regeneration in the animal model. Trans Persatuan Genetik Malaysia (TPGM) 7:201–210
Munirah S, Zainul Ibrahim Z, Rozlin AR et al (2014) Exploring the islamic perspective on tissue engineering principles and practice. Comm Publ Ethics 4(2):29–40
Nazir NM, Sha’ban M (2018) Overview of safety and efficacy of non-viral gene transfer in cartilage tissue engineering from the worldview of Islam. Int Med J Malaysia 17:115–123
Willerth SM, Sakiyama-Elbert SE (2008) Combining stem cells and biomaterial scaffolds for constructing tissues and cell delivery. StemBook, Washington University
Tahir AHMA, Amin MAIM, Azhim A (2018) Evaluation of cartilaginous extracellular matrix production in in vitro “cell-scaffold” construct. In: 2018 IEEE-EMBS Conference on Biomedical Engineering and Sciences (IECBES), pp 500–504
Munirah S, Samsudin OC, Chen HC et al (2007) Articular cartilage restoration in load-bearing osteochondral defects by autologous chondrocytes-fibrin constructs implantation: an experimental study in sheep. J Bone Joint Surg (Br) 89B:1099–1109
Hazwani A, Sha’ban M, Azhim A (2017) Inflammatory response of bioscaffolds decellularized by sonication treatment. In: International conference for innovation in biomedical engineering and life sciences 2017, pp 183–185
Mohamed Amin MAI, Tahir AHMA, Azhim A et al (2018) Physical properties and biocompatibility of 3D hybrid PLGA based scaffolds. In: 2018 IEEE-EMBS Conference on Biomedical Engineering and Sciences (IECBES), pp 480–484
Martín-Martín A, Orduna-Malea E, Thelwall M et al (2018) Google scholar, web of science, and scopus: a systematic comparison of citations in 252 subject categories. J Informet 12(4):1160–1177
Ovsianikov A, Khademhosseini A, Mironov V (2018) The synergy of scaffold-based and scaffold-free tissue engineering strategies. Trends Biotechnol 36(4):348–357
He D, Zhao AS, Su H et al (2019) An injectable scaffold based on temperature-responsive hydrogel and factor-loaded nanoparticles for application in vascularization in tissue engineering. J Biomed Mater Res A 107(A):2123–2134
Kelly DC, Raftery RM, Curtin CM et al (2019) Scaffold-based delivery of nucleic acid therapeutics for enhanced bone and cartilage repair. J Orthop Res 37:1671–1680
Wen YT, Dai NT, Hsu SH (2019) Biodegradable water-based polyurethane scaffolds with a sequential release function for cell-free cartilage tissue engineering. Acta Biomater 88:301–313
Kobayashi J, Kikuchi A, Aoyagi T (2019) Cell sheet tissue engineering: cell sheet preparation, harvesting/manipulation, and transplantation. J Biomed Mater Res A 107(5):955–967
Takahashi H, Okano T (2015) Cell sheet-based tissue engineering for organizing anisotropic TEMPs produced using microfabricated thermoresponsive substrates. Adv Healthc Mater 4(16):2388–2407
Antunes J, Gaspar VM, Ferreira L et al (2019) In-air production of 3D co-culture tumor spheroid hydrogels for expedited drug screening. Acta Biomater 94:392–409
Akkouch A, Yu Y, Ozbolat IT (2015) Microfabrication of scaffold-free tissue strands for three-dimensional tissue engineering. Biofabrication 7(3):031002
Yu Y, Moncal KK, Li J et al (2016) Three-dimensional bioprinting using self-assembling scalable scaffold-free “tissue strands” as a new bioink. Sci Rep 6(1):28714
Yamato M, Okano T (2004) Cell sheet engineering. Mater Today 7(5):42–47
Acknowledgement
The authors thanked the Ministry of Education (MOE) Malaysia Transdisciplinary Research Grant Scheme TRGS/1/2016/UIAM/02/8/2 (TRGS16-02-002-0002) under TRGS/1/2016/UIAM/02/8 programme and the Ministry of Energy, Science, Technology, Environment and Climate Change (MESTECC, formerly known as MOSTI) Malaysia Science Fund (SF14-012-0062/06-01-08-SF0238); the Kulliyyah of Allied Health Sciences, International Islamic University Malaysia (IIUM), Kuantan Campus, Pahang, Malaysia; and Tissue Engineering and Regenerative Medicine Research Team, IIUM, for their support.
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Appendix
Appendix
List of biomaterial scaffolds used as an individual or in combination in cartilage tissue engineering experimentation based on 1645 studies starting 1994 to 2017. Note Table (A) natural biomaterials and (B) synthetic biomaterials.
(A) Natural biomaterials |
---|
1. Agarose |
2. Collagen type I (Integra®) commercial |
3. Hyaluronic acid (HYAFF®-11) |
4. Fibrin |
5. Alginate |
6. Collagen I |
7. Collagen I/GAG |
8. Gelatin |
9. Calcium phosphate tribasic |
10. Collagen type I |
11. Collagen II |
12. Hyaluronic acid, alginate (NS) [NS] |
13. Silicone rubber membranes coated with type I collagen; ~agarose |
14. Atelocollagen I |
15. Silk fibroin |
16. Calcium polyphosphate |
17. Chitosan |
18. HYAFF-11; HYAFF-11-S |
19. Sodium alginate |
20. Methacrylated form of hyaluronan (HA-MA) (hydrogel, cylindrical) [Photocross-linking] |
21. Collagen type I (Cellagen™) commercial |
22. Self-assembling collagen type I |
23. Alginate; agarose; gelatin; fibrin |
24. Agarose; alginate; gelatin |
25. B-TCP |
26. Cartilage ECM |
27. Hyaluronic acid methacrylated |
28. Bacterial cellulose; collagen type II; alginate |
29. Hyaluronan |
30. Self-assembled (collagen type II-coated; aggrecan-coated); ~agarose |
31. Collagen I; II; III |
32. Pellet; ~atelocollagen |
33. Fibrinogen |
34. Hyaluronic acid;{atelocollagen} |
35. Hyaluronic acid (HA) hydrogels (2 wt% 1100 kDa, 2 wt% 350 kDa, 5 wt% 350 kDa, 2 wt% 50 kDa, 5 wt% 50 kDa, 10 wt% 50 kDa; 20 wt% 50 kDa) |
36. Pellet; ~collagen |
37. Macroporous gelatin-coated microcarrier beads CultiSpher |
38. Gelatin (photopolymerisable styrenated gelatin) |
39. Alginate beads; agarose |
40. CaReS (rat-tail collagen type I); atelocollagen (bovine collagen type I); dermal regeneration template (bovine collagen type I); Chondro-Gide (bovine collagen type I/III); atelocollagen honeycomb small (bovine collagen type I); atelocollagen honeycomb large (bovine collagen type I) |
41. Human amniotic membrane (epithelial side of intact HAM (IHE), basement side of denuded HAM (DHB) and stromal side of denuded HAM (DHS)) |
42. Collagen type I (Resorba®) commercial |
43. Collagen |
44. ECM (cell-derived) |
45. Pellets vitro and vivo; ~alginate gel vivo |
46. Micromass; collagen honeycomb |
47. Osteochondral cores (cylindrical) [NS] |
48. Collagen I (Antema®) commercial |
49. Pellet → engineered ECM |
50. Collagen type II |
51. Alginate hydrogel; agarose hydrogel |
52. Hyaluronan biomaterial (HYAFF-11, Fidia) {cylinder} [NS] |
53. Alginate bead → coralline hydroxyapatite |
54. Hyaluronic acid {hydrogels} |
55. Decellularised (cartilage ECM) |
56. Collagen I (Helistat®) commercial |
57. Chitosan + Arg-Gly-Asp (RGD); chitosan + epidermal growth factor (EGF) |
58. Coral |
59. Whole blood, agarose |
60. Cell sheet → cell plate in culture insert; ~atelocollagen honeycomb-shaped |
61. Chitin (di-butyryl-chitin) |
62. Alginate beads → calcium phosphate Calcibon® |
63. Cellulose |
64. Gellan gum |
65. Hyaluronic acid HA (0.5, 1 and 2 g) |
66. Aragonite matrix |
67. Layered agarose hydrogel |
68. Chondron ECM |
69. Cross-linked methacrylated hyaluronic acid hydrogels (MeHA);{agarose} |
70. HA; agarose {gel} |
71. Collagen II (recombinant human) |
72. Calcium alginate |
73. Gelatin, chitosan (cylindrical) [NS] |
74. Gellan um;{agarose} |
75. Alginate (hydrogel) [NS]; demineralised bone matrix (NS) [3D printing] |
76. Atelocollagen |
77. Hyaluronic acid (nonwoven mesh) [NS] |
78. Decellularised (osteochondral graft) |
79. Demineralised joint condyle |
80. Alginate beads; ~hydroxyapatite (HA) carrier |
81. Collagen type I (CaRes®) |
82. Collagen I (CaReS®) |
83. Hydroxyapatite, chitin, chitosan (NS) [NS] |
84. Collagen type I (Arthro Kinetics Biotechnology) |
85. Collagen (Chondro-Gide®) |
86. Pellet; cross-linkable hyaluronan hydrogel |
87. Decellularised osteochondral explant |
88. Gelatin; chitosan |
89. Silk fibroin;{hyaluronic acid (HYAFF®-11)} |
90. Fibrin glue hydrogel; platelet-rich fibrin glue hydrogel; fibrin glue hydrogel containing heparin-binding delivery system; platelet-rich fibrin glue hydrogel containing heparin-binding delivery system |
91. Nonbiomedical and biomedical grade alginates |
92. Collagen I (Porcogen™) |
93. Sodium alginate (Sea Matrix®) |
94. Methacrylated glycol chitosan |
95. Collagen type I, collagen type III (disc) [NS] |
96. Self-assembled; fibrin |
97. Collagen I (Ultrafoam®) commercial |
98. Pellet culture; agarose |
99. Hyaluronic acid (HA) hydrogel; agarose hydrogel |
100. Hyaluronic acid methacrylated; agarose |
101. κ-Carrageenan |
102. “Hydrogel: (1) soluble rat-tail type I collagen (0.2% w/v) (BD Biosciences, San Jose, CA, USA); (2) type I collagen (0.2%) incorporating transglutaminase (TG)-2 (100 lgml–1) (Sigma); (3) type I collagen (0.2%) incorporating microbial transglutaminase (mTG; 100 lg ml–1) (Ajinomoto Food Ingredients LLC, Chicago, IL); (4) type I collagen (0.2%) incorporating genipin (GP, 0.25 mM) (Wako, Richmond, VA, USA); (5) type I collagen (0.2%) incorporating GP (0.25 mM) and control agarose beads (without heparin) (Sigma); and (6) type I collagen (0.2%) incorporating GP (0.25 mM) and heparin-agarose type I beads (10% weight of heparin/weight of collagen) (Sigma) |
103. Sponge-like scaffolds were prepared: (1) porcine type I/III collagen (CI) (0.5% w/v) (Geistlich Biomaterials, Wolhusen, Switzerland); (2) CI (0.5%) additionally supplemented with CS (7% w/w relative to CI) (Sigma Chemical Co., St Louis, MO, USA); and (3) CI (0.5%) additionally supplemented with HS (7% w/w relative to CI) (Sigma)” |
104. Cell pellet – collagen type II nanoarchitectured molecules; collagen fibrils (CNFs); collagen spheres (CNPs) |
105. Gelatin; chitosan; agarose |
106. Decellularised (dermal ECM) |
107. Hyaluronic acid (HYAFF®-11); collagen (Bio-Gide®) commercial |
108. Self-assembled (agarose mould) → collagen cross-linking via lysyl oxidase (timing) |
109. Collagen type I (PureCol®) commercial |
110. Bacterial cellulose |
111. Pellet culture (aggregate);~micromass (self-assembled) in plate; ~collagen II |
112. Devitalised cartilage explant |
113. Alginate (beads) [NS]; cell pellet (NS) [NS]; collagen, chitosan (NS) [NS] |
114. Alginate bead → scaffold free on b-tricalcium phosphate carriers [] |
115. Fibrin hydrogel in agarose well; agarose well only |
116. Osteochondral cores, agarose (disc) [NS] |
117. Extracellular matrix (ECM) by ASCs; ECM by synovium-derived stem cells (SDSCs). The cell in pellet condition |
118. TCP |
119. Glycerol phosphate |
120. Decalcified bone matrix |
121. Hyaluronic acid hydrogel |
122. Recombinant human collagen type II (Fibrinogen Europe, Helsinki, Finland) |
123. PRP |
124. Micromass; pellet culture model; vivo~fibrin gel |
125. Injectable hydroxypropylmethylcellulose (HPMC) hydrogel |
126. Hyaluronic acid methacrylate (HA-MA), chondroitin sulphate methacrylate (CS-MA); (hydrogel) [NS] |
127. Collagen type I, collagen type III (NS) [NS] |
128. Sulphated alginate |
129. Agarose; plasma; whole blood |
130. Photocross-linkable gelatin-methacrylamide (Gel-MA); varying concentrations (0–2%) of hyaluronic acid methacrylate (HA-MA) |
131. Human acellular cartilage matrix powders |
132. Self-assembled (polyethylene terephthalate (PET)-coated); agarose hydrogel encapsulation |
133. Methacrylated gelatin |
134. ECM (MSC-derived) |
135. Demineralised bone matrix |
136. Hybrid organic-inorganic (HOI) material photopolymer ORMOSIL SZ2080; ∗collagen type I membrane |
137. Decellularised (meniscus ECM) |
138. Alginate; chitosan; fibrin |
139. Heparin-conjugated fibrin (gel) [NS] |
140. Microcavitary alginate hydrogel (microsphere) |
141. Chondroitin sulphate methacrylate |
142. Micromass cell pellets; alginate hydrogels |
143. 45S5 Bioglass® |
144. Graphene oxide (NS) [NS] |
145. Amniotic membrane |
146. Hyaluronic acid (NS) [NS] |
147. Collagen type I, collagen type II, hydroxyapatite (cylindrical) [NS] |
148. Porcine articular cartilage extracellular matrix (ACECM) (disc) [directional crystallisation and freeze-drying] |
149. Cartilage ECM powder |
150. Self-assembled; ~alginate |
151. Pellet; ECM hydrogel |
152. RGD-immobilised microcavitary alginate hydrogels; microcavitary alginate hydrogel |
153. Gelatin methacryloyl |
154. Gelatin methacrylamide (GelMA), hyaluronic acid methacrylate (HAMA), alginate (ALG), hydroxyapatite paste (HAP) (hydrogel) [3D printing] |
155. Chitosan; alginate; collagen I |
156. Demineralised cancellous bone |
157. Human dermal fibroblast-derived ECM (hECM) |
158. Decellularised (cartilage ECM) and methacrylated; methacrylated gelatin |
159. Calcium-cobalt alginate |
160. Devitalised cartilage |
161. Transglutaminase-cross-linked hyaluronan hydrogels (HA-TG); alginate |
162. Pellet; alginate bead; {monolayer} |
163. ECM |
164. Alginate; agarose |
165. Decellularised (bone matrix) and demineralised |
166. Gelatin methacrylamide; polyacrylamide |
167. Pellets; agarose |
168. Monomeric type I and type II collagen |
169. Sodium alginate, collagen type I, collagen type II, chondroitin sulphate (hydrogel) [NS] |
(B) Synthetic biomaterials |
---|
1. 2-Hydroxyethyl methacrylate-L-lactate–dextran (HEMA–LLA–D) |
2. B-TCP |
3. Calcium carbonate (Calcibon®) |
4. Calcium polyphosphate |
5. Cell pellet; ~PLGA |
6. Collagen-like proteins |
7. Compact polyelectrolyte complexes (CoPECs) |
8. Elastin-like polypeptide (ELP) |
9. Hyaluronan benzyl ester (disc) [NS] |
10. Injectable PLGA microsphere |
11. Macromers of PEG-caprolactone (PEG-CAP) endcapped with norbornene (PEG-CAP-NOR) |
12. Nonporous microcarriers poly(lactic-co-glycolic acid) (PLGA); porous PLGA; amine-functionalised PLGA-NH2 |
13. Nonwoven PGA fibres |
14. Nonwoven polyethylene terephthalate fibre |
15. NS polycarbonate membrane |
16. Oligo(trimethylene carbonate)-poly(ethylene glycol)-oligo (trimethylene carbonate) diacrylate (TPT-DA) |
17. OPF |
18. PBT |
19. PCL |
20. PEG |
21. PEG hydrogel; PLGA microfibers |
22. PEGDA |
23. PEGDM |
24. PEG–oligo(lactic acid) dimethacrylate PEG–LA-DM |
25. Peptide-modified PEGDA (hydrogel) [NS] |
26. PGA |
27. PGA; PLGA (disc) [NS] |
28. PGA; PLLA; PDLLA; PLGA; PCL |
29. PGA-PLA (Ethisorb 210); poly-L-lactic acid |
30. PGLA (polyglycollic-co-lactic acid) |
31. PHBV (3-hydroxybutrate-co-3-hydroxyvalerate) |
32. PLA |
33. PLA (OPLA®) |
34. PLA; PGA; PLGA |
35. PLAG |
36. PLCL |
37. PLG |
38. PLGA |
39. PLGA, poly(ethy1ene oxide)-dimethacrylate, poly(ethy-1-ene glycol) (NS) [double emulsion] |
40. PLGA; polydioxanone (PDO) |
41. PLGA-fleece (darts) [NS] |
42. PLLA |
43. PLLA (NS) [electrospinning] |
44. PLLA (RESOMERL207S) |
45. PLLA; PLGA(L); PLGA(H); PLA/CL; PDLA |
46. PLLA; PGA; PLGA; PLAO3 |
47. Poly(1,8-octanediol citrate) |
48. Poly(2-acrylamido-2-methyl-1-propanesulfonic acid (NaAMPS)-co-N,N-dimethylacrylamide(DMAAm)) |
49. Poly(2-hydroxyethyl methacrylate) |
50. Poly(3-hydroxybutyrate-co-3-hydroxyhexanoate) (PHBHHx) |
51. Poly(3-hydroxybutyrate-co-4-hydroxybutyrate) (P3HB4HB) |
52. Poly(ethyl acrylate-co-hydroxyethyl acrylate) [P(EA-co-HEA)] |
53. Poly(ethylene oxide) dimethacrylate (PEODM) |
54. Poly(ethylene terephthalate) (PET) |
55. Poly(glycerol sebacate) (PGS) |
56. Poly(hydroxybutyrate-co-hydroxyvalerate) (PHBV) |
57. Poly(lactic-glycolic acid) (PLGA) |
58. Poly(L-lactide-co-e-caprolactone) (PLCL) (NS) [supercritical fluid foaming; solvent-casting and salt leaching method] |
59. Poly(L-lactide-co-e-caprolactone) (PLCL) {sponge} [supercritical fluid foaming; solvent-casting and salt leaching method] |
60. Poly(L-lactide-co-e-caprolactone) (PLCL); articular cartilage explant (control) |
61. Poly(N-isopropylacrylamide)-g-methylcellulose (PNIPAAm-g-MC) thermoreversible hydrogel |
62. Poly(N-isopropylacrylamide-co-acrylic acid) (p(NiPAAm-co-AAc)) (hydrogel) [NS] |
63. Poly(N-isopropylacryl-amide-co-acrylic acid) thermoreversible gel |
64. Poly(propylene fumarate-co-ethylene glycol) [P(PF-co-EG)]; {agarose}; {alginate} |
65. Poly(urethane urea) Artelon® |
66. Poly(γ-benzyl-L-glutamate) (PBLG) |
67. Poly(ε-caprolactone) (PCL) nanofibrous electrospinning |
68. Poly3-hydroxybutyrate4-hydroxybutyrate (P34HB) |
69. Polycaprolactone; poly(L-lactide); poly(lactic-co-glycolic acid); polyurethane |
70. Polydimethylsiloxane (PDMS) |
71. Polydimethylsiloxane (PDMS) concave microwells |
72. Polyester poly(3-hydroxybutyrate) (PHB) film |
73. Polyethylene glycol diacrylate |
74. Polyglycolic acid (PGA) |
75. Polyglycolic acid (PGA); cartilage explant |
76. Polyglycolic acid (PGA); poly(glycolic acid-e-caprolactone) (PGCL); poly(l-lactic acid-glycolic acid) (PLGA), poly(l-lactic acid-e-caprolactone;75:25 (w/w)) [P(LA-CL)25]; poly-e-caprolactone (tetrabutoxy titanium) [PCL(Ti)]; fullerene C-60 dimalonic acid (DMA) |
77. PolyHIPE polymer (PHP) |
78. Polyhydroxyalkanoate (PHA) = poly[(R)-3-hydroxybutyrate-co-(R)-3-hydroxy-10-38 undecenoate] (PHBU) |
79. Poly-L,D-lactic acid (PLDLA) |
80. Polylactic acid (PLA); Acrylonitrile butadiene styrene (ABS) (NS) [3D printing] |
81. Polylactic acid poly-e-caprolactone (PLCL) |
82. Polylactic acid-polyglycolic acid (PLGA) |
83. Polylactic glycolic acid (PLGA) |
84. Polylactic glycolic acid (PLGA) |
85. “Polylactic glycolic |
86. acid (3D-PLGA) (NS) [NS]” |
87. Polylactide-polyglycolic acid (PLGA) |
88. Polylactide-co-glycolide (PLGA) 85:15 microspheres/biodegradable hydrogel |
89. Poly-L-lactic acid (PLLA) |
90. Poly-L-lactic acid (PLLA) microsphere; poly-L-lactic acid (PLLA) microsphere + tripeptide Arg-Gly-Asp |
91. Polymer solutions of poly(ethylene) oxide diacrylate |
92. Polyurethane |
93. Polyurethane (PU); poly(L/DL-lactide) (PLA)-control |
94. Polyurethane/poly(L-lactide-co-D, llactide) (PU/PLDL) [6:4; 5:5; 8:2] |
95. Poly-ε-caprolactone (NS) [electrospinning] |
96. PuraMatrix (hydrogel) [NS] |
97. PVA |
98. Recombinant streptococcal collagen-like 2 (Scl2) protein with heparin-binding, integrin-binding and hyaluronic acid-binding peptide sequences (HIHA) [nonviral bacteria]. ScrMMP7-HIHA-Scl2, MMP7-HIHAScl2, MMP7:ACAN(75:25)-HIHA-Scl2, MMP7:ACAN(50:50)-HIHAScl2, MMP7:ACAN(25:75)-HIHA-Scl2 and ACAN-HIHA-Scl2 hydrogels. |
99. Self-assembling peptide (KLD) AcN-(KLDL)3-CNH2 |
100. Self-assembling peptide (KLD); cartilage explants |
101. Self-assembling peptide (KLDL) |
102. Self-assembling peptide (RADA)4 |
103. Self-assembling peptide AcN–(KLDL)3–CNH2 hydrogels;{agarose} |
104. Self-assembly aggrecan (0.6% w/w), aggrecan–HA (0.6% w/w) and HA (1% w/w) solutions; ~type II collagen/aggrecan; ~PVA hydrogel |
105. Silanised hydroxypropyl methylcellulose (Si-HPMC) hydrogel [E4M®] |
106. Silated hydroxypropyl methylcellulose (hydrogel) [NS] |
107. Silk; collagen; gelatin |
108. Silk-elastin-like-protein polymer SELP-47 K |
109. Sodium cellulose sulphate; polydiallyl dimethyl ammonium chloride (NS) [NS] |
110. Tantalum |
111. Tetramethacrylate prepolymer |
112. Thermoreversible gelation polymer [poly(N-isopropylacrylamide-co-n-butyl methacrylate) (poly(NIPAAm-co-BMA))] |
113. Titanium |
Rights and permissions
Copyright information
© 2020 Springer Nature Singapore Pte Ltd.
About this chapter
Cite this chapter
Sha’ban, M., Ahmad Radzi, M.A. (2020). Scaffolds for Cartilage Regeneration: To Use or Not to Use?. In: Chun, H.J., Reis, R.L., Motta, A., Khang, G. (eds) Bioinspired Biomaterials. Advances in Experimental Medicine and Biology, vol 1249 . Springer, Singapore. https://doi.org/10.1007/978-981-15-3258-0_7
Download citation
DOI: https://doi.org/10.1007/978-981-15-3258-0_7
Published:
Publisher Name: Springer, Singapore
Print ISBN: 978-981-15-3257-3
Online ISBN: 978-981-15-3258-0
eBook Packages: Biomedical and Life SciencesBiomedical and Life Sciences (R0)